Original language | English |
---|---|
Pages (from-to) | 960-970 |
Number of pages | 11 |
Journal | The Lancet Diabetes and Endocrinology |
Volume | 8 |
Issue number | 12 |
DOIs | |
Publication status | Published - 2020 |
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
K Clément, Erica Akker, J Argente, A Bahm, Kuan Chung, H Connors
Research output: Contribution to journal › Article › Academic › peer-review